Lessons from a multicentre retrospective study of peptide receptor radionuclide therapy combined with lanreotide for neuroendocrine tumours: a need for standardised practice

Prasad, Vikas; Srirajaskanthan, Raj; Toumpanakis, Christos; Grana, Chiara Maria; Baldari, Sergio; Shah, Tahir; Lamarca, Angela; Courbon, Frederic; Scheidhauer, Klemens; Baudin, Eric; Thanh, Xuan-Mai Truong; Houchard, Aude; Dromain, Clarisse; Bodei, Lisa

Erstveröffentlichung

2020

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Prasad, Vikas

Srirajaskanthan, Raj

Toumpanakis, Christos

Grana, Chiara Maria

Baldari, Sergio

et al.

Institutions

UKU. Klinik für Nuklearmedizin

Published in

European journal of nuclear medicine & molecular imaging. - : Springer, . - ISSN 1619-7070. - eISSN 1619-7089

Link to publication

https://dx.doi.org/10.1007/s00259-020-04712-2

Keywords

Peptide receptor radionuclide therapy; Lu-177-DOTATOC; Lu-177-DOTATATE; Lanreotide; Neuroendocrine tumours; RADIOLABELED SOMATOSTATIN ANALOG; ENETS CONSENSUS GUIDELINES; BONE METASTASES; GROWTH-RATE; TYR(3) OCTREOTATE; CARCINOID-TUMORS; PHASE-3 TRIAL; EFFICACY; LU-177-DOTA(0); TOXICITY

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record